Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Emergency Medicine Journal : EMJ
|
September 5, 2003
How well does decision support software perform in the emergency department?
M A Graber, D VanScoy
Currents in Pharmacy Teaching & Learning
|
June 23, 2020
Rebooting a sports pharmacy advanced pharmacy practice experience: Utilizing medicinal chemistry as a foundational approach to get pharmacists back in the game
Matthew J DellaVecchia, Richard J Marrero, Jenna L James, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model
Arnold Louie, Brian D VanScoy, David L Brown, et al.
Antimicrobial Agents and Chemotherapy
|
February 9, 2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber <i>In Vitro</i> Infection Model
B D VanScoy, S Jones, H Conde, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity
Paul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2011
Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis
Arnold Louie, Daniel S Stein, Julia Z Zack, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model
Brian D VanScoy, Michael Trang, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy
|
April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection Model
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2017
Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor
Paul G Ambrose, Brian D VanScoy, Michael Trang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Emergency Medicine Journal : EMJ
|
September 5, 2003
How well does decision support software perform in the emergency department?
M A Graber, D VanScoy
Currents in Pharmacy Teaching & Learning
|
June 23, 2020
Rebooting a sports pharmacy advanced pharmacy practice experience: Utilizing medicinal chemistry as a foundational approach to get pharmacists back in the game
Matthew J DellaVecchia, Richard J Marrero, Jenna L James, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model
Arnold Louie, Brian D VanScoy, David L Brown, et al.
Antimicrobial Agents and Chemotherapy
|
February 9, 2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber <i>In Vitro</i> Infection Model
B D VanScoy, S Jones, H Conde, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity
Paul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2011
Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis
Arnold Louie, Daniel S Stein, Julia Z Zack, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model
Brian D VanScoy, Michael Trang, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy
|
April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection Model
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2017
Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor
Paul G Ambrose, Brian D VanScoy, Michael Trang, et al.
Page
of 3